On The Record | A Compex Blog

Recent Legislation and Judicial Decisions Shaping Mass Torts in 2025

Written by Kevin Plankey | Feb 19, 2025 1:14:39 PM

The mass tort landscape is continuously evolving, influenced by new legislation and judicial decisions that shape how cases are managed, litigated, and resolved. As we step into 2025, several recent developments are poised to have significant effects on the mass tort industry. These changes, whether at the federal or state level, impact everything from the procedures surrounding claims to the types of cases that are more likely to emerge. In this blog, we’ll explore some of the key legislative and judicial changes that will affect mass torts in the coming year.

Recent Legislation Shaping Mass Tort Cases

1. Class Action Fairness Act (CAFA) Amendments

The Class Action Fairness Act (CAFA) has been a critical piece of legislation governing class action lawsuits and mass tort claims for years. However, recent amendments to CAFA may have significant implications for how mass tort cases are handled, especially regarding the consolidation of cases. In 2025, further adjustments to CAFA are expected, which may make it more challenging for plaintiffs to bring cases together in one jurisdiction. Additionally, stricter requirements for demonstrating commonality among class members could result in more cases being denied certification, potentially leading to more fragmented litigation.

2. State-Based Tort Reform

Various states have implemented tort reform measures over the past few years, but several are now considering new reforms that could further limit plaintiffs’ ability to pursue mass tort claims. In particular, states like Texas and California are exploring ways to streamline the litigation process, potentially limiting the scope of damages in mass tort cases or imposing stricter requirements on plaintiffs’ ability to file lawsuits. These state-based reforms will likely influence the strategy and approach to mass tort cases in 2025, especially in jurisdictions that are traditionally viewed as more plaintiff-friendly.

3. The “Right to Know” Laws

With increasing consumer concerns about product safety and corporate accountability, some states are passing "Right to Know" laws. These laws allow consumers greater access to information about the risks associated with products they purchase, including pharmaceuticals, medical devices, and chemicals. These laws are likely to play a significant role in future mass tort claims, as plaintiffs’ attorneys will have better access to evidence about corporate misconduct, which can strengthen the foundation of mass tort lawsuits in 2025 and beyond.

Judicial Decisions Impacting Mass Tort Litigation

1. Janssen v. State of California (2024)

In one of the most closely watched decisions from the previous year, the California Supreme Court ruled on the case of Janssen v. State of California, which involved the potential liability of pharmaceutical companies for failure to warn consumers about the risks of their products. This landmark decision, which involves the state’s interpretation of failure-to-warn laws, is expected to influence how pharmaceutical companies approach product warnings in the future. For mass tort cases involving drugs and medical devices, this ruling will likely increase the number of cases where plaintiffs can establish liability against manufacturers.

2. Precedent-Setting Product Liability Rulings

In 2024, several significant product liability cases were decided in courts across the country, particularly with defective medical devices and toxic chemicals. These decisions have set important precedents for how juries will be instructed to evaluate damages in mass tort cases. Going into 2025, plaintiffs in these types of cases may find it easier to prove causation, while defendants may face greater challenges in rebutting claims. Expect more courts to adopt these precedents, particularly in cases involving high-profile defendants such as pharmaceutical companies and multinational corporations.

3. Asbestos Litigation Developments

Asbestos litigation continues to be one of the most significant areas of mass tort law, with cases dating back decades still pending. In 2024, several judicial decisions further clarified how claims related to asbestos exposure will be handled moving into 2025. One notable decision involved the limitation of claims for individuals who were exposed to asbestos but did not show symptoms for many years. This decision is expected to narrow the scope of certain claims and may affect how future asbestos-related mass tort cases are filed and resolved.

4. The Impact of Multi-District Litigation (MDL) Procedures

MDL procedures have long been used to consolidate mass tort cases, but recent judicial decisions are reshaping how MDLs are handled. As courts face increased volume in mass tort cases, there are growing calls for tighter controls over MDLs to ensure efficiency while still protecting plaintiffs' rights. Some courts are leaning toward stricter case management, potentially imposing deadlines for discovery, depositions, and settlement discussions. This is likely to influence the overall speed and cost of mass tort litigation moving into 2025.

How These Changes Will Affect Mass Tort Cases in 2025

The combination of new legislation and judicial decisions means that mass tort cases in 2025 will likely become more complex and strategically nuanced. Plaintiffs will need to navigate a shifting legal landscape, adjusting their approaches to take advantage of new legal opportunities while being mindful of the growing challenges posed by tort reform and increasingly stringent case management procedures.

For attorneys handling mass tort cases, staying abreast of these legislative and judicial changes will be critical to ensuring success. The ability to anticipate how these changes will impact each case—whether by adjusting strategies, modifying timelines, or understanding jurisdictional challenges—will be key to obtaining favorable outcomes for clients.

Learn more about how Compex Legal Services can also assist you with leveraging technology for all your record retrieval, medical record insights, deposition reporting, and IME needs.